Advocacy intelligence hub — real-time data for patient organizations
University of Alabama at Birmingham — PHASE4
Avni Joshi — PHASE2
National Cancer Institute (NCI) — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all OBSOLETE: Common variable immunodeficiency due to TNFR deficiency news →
View all OBSOLETE: Common variable immunodeficiency due to TNFR deficiency specialists →